AVTO

 
Common Stock SEC Reporting - Delinquent
Pink No Information
Contact Info
  • 530 South Lake Avenue
  • #363
  • Pasadena, CA 91101

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Not Available
Latest Report Dec 31, 2001 10-K
CIK 0000894538
Fiscal Year End Not Available
OTC Marketplace Pink No Information
Profile Data
SIC - Industry Classification 9995 - Non-Operating Establishments
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
William Ardrey CEO
Angela Bronow Davanzo CFO
Company Directors
Not Available
Service Providers
Accounting/Auditing Firm

Not Available
Securities Counsel

Not Available
Investor Relations Firm

Not Available
Company History
  • Formerly=Innovate Oncology, Inc. until 7-06
  • Note=12-31-04 company is in the development stage
  • Formerly=Hampton Berkshire Insurance & Financial, Inc. until 10-04
  • Formerly=First Capital Resources.com, Inc. until 3-03
  • Formerly=Jackal Industries, Inc. until 4-99
AVTO Security Details
Share Structure
Market Value1 $891,390 a/o Oct 18, 2017
Authorized Shares 125,000,000 a/o Oct 18, 2017
Outstanding Shares 74,282,472 a/o Oct 18, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC 2,034,307 a/o Oct 18, 2017
Float Not Available
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
Continental Stock Transfer & Trust Company
Shareholders
Shareholders of Record Not Available
Short Selling Data
Short Interest 0 (-100%)
Aug 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security